Export your current network:
... as a bitmap image:
file format is 'PNG': portable network graphic
... as a high-resolution bitmap:
same PNG format, but at higher resolution
... as a vector graphic:
SVG: scalable vector graphic - can be opened and edited in Illustrator, CorelDraw, Dia, etc
... as short tabular text output:
TSV: tab separated values - can be opened in Excel and Cytoscape (lists only one-way edges: A-B)
... as tabular text output:
TSV: tab separated values - can be opened in Excel (lists reciprocal edges: A-B,B-A)
... as an XML summary:
structured XML interaction data, according to the 'PSI-MI' data standard
... protein node degrees:
node degree of proteins in your network (given the current score cut-off)
... network coordinates:
a flat-file format describing the coordinates and colors of nodes in the network
... protein sequences:
MFA: multi-fasta format - containing the aminoacid sequences in the network
... protein annotations:
a tab-delimited file describing the names, domains and descriptions of proteins in your network
... functional annotations:
a tab-delimited file containing all known functional terms of protiens in your network
Browse interactions in tabular form:
node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
AGO2 | NPM1 | ENSOANP00000011335 | ENSOANP00000012412 | Protein argonaute-2; Required for RNA-mediated gene silencing (RNAi) by the RNA- induced silencing complex (RISC). The 'minimal RISC' appears to include AGO2 bound to a short guide RNA such as a microRNA (miRNA) or short interfering RNA (siRNA). These guide RNAs direct RISC to complementary mRNAs that are targets for RISC-mediated gene silencing. The precise mechanism of gene silencing depends on the degree of complementarity between the miRNA or siRNA and its target. Binding of RISC to a perfectly complementary mRNA generally results in silencing due to endonucleolytic cleavage of the [...] | Nucleophosmin 1. | 0.711 |
AGO2 | TP53 | ENSOANP00000011335 | ENSOANP00000018980 | Protein argonaute-2; Required for RNA-mediated gene silencing (RNAi) by the RNA- induced silencing complex (RISC). The 'minimal RISC' appears to include AGO2 bound to a short guide RNA such as a microRNA (miRNA) or short interfering RNA (siRNA). These guide RNAs direct RISC to complementary mRNAs that are targets for RISC-mediated gene silencing. The precise mechanism of gene silencing depends on the degree of complementarity between the miRNA or siRNA and its target. Binding of RISC to a perfectly complementary mRNA generally results in silencing due to endonucleolytic cleavage of the [...] | P53 domain-containing protein. | 0.438 |
CASP2 | NPM1 | ENSOANP00000005545 | ENSOANP00000012412 | Caspase 2; Belongs to the peptidase C14A family. | Nucleophosmin 1. | 0.701 |
CASP2 | TP53 | ENSOANP00000005545 | ENSOANP00000018980 | Caspase 2; Belongs to the peptidase C14A family. | P53 domain-containing protein. | 0.507 |
CENPA | NPM1 | ENSOANP00000000820 | ENSOANP00000012412 | Centromere protein A. | Nucleophosmin 1. | 0.694 |
F6STU0_ORNAN | MDM2 | ENSOANP00000003560 | ENSOANP00000009459 | ANK_REP_REGION domain-containing protein. | MDM2 proto-oncogene. | 0.994 |
F6STU0_ORNAN | NPM1 | ENSOANP00000003560 | ENSOANP00000012412 | ANK_REP_REGION domain-containing protein. | Nucleophosmin 1. | 0.792 |
F6STU0_ORNAN | TP53 | ENSOANP00000003560 | ENSOANP00000018980 | ANK_REP_REGION domain-containing protein. | P53 domain-containing protein. | 0.982 |
FLT3 | NPM1 | ENSOANP00000014439 | ENSOANP00000012412 | Fms related tyrosine kinase 3; Belongs to the protein kinase superfamily. Tyr protein kinase family. CSF-1/PDGF receptor subfamily. | Nucleophosmin 1. | 0.820 |
K7EDB6_ORNAN | MDM2 | ENSOANP00000031523 | ENSOANP00000009459 | Uncharacterized protein. | MDM2 proto-oncogene. | 0.865 |
K7EDB6_ORNAN | NCL | ENSOANP00000031523 | ENSOANP00000013915 | Uncharacterized protein. | Uncharacterized protein. | 0.484 |
K7EDB6_ORNAN | NPM1 | ENSOANP00000031523 | ENSOANP00000012412 | Uncharacterized protein. | Nucleophosmin 1. | 0.696 |
K7EDB6_ORNAN | TP53 | ENSOANP00000031523 | ENSOANP00000018980 | Uncharacterized protein. | P53 domain-containing protein. | 0.614 |
MDM2 | F6STU0_ORNAN | ENSOANP00000009459 | ENSOANP00000003560 | MDM2 proto-oncogene. | ANK_REP_REGION domain-containing protein. | 0.994 |
MDM2 | K7EDB6_ORNAN | ENSOANP00000009459 | ENSOANP00000031523 | MDM2 proto-oncogene. | Uncharacterized protein. | 0.865 |
MDM2 | NCL | ENSOANP00000009459 | ENSOANP00000013915 | MDM2 proto-oncogene. | Uncharacterized protein. | 0.481 |
MDM2 | NPM1 | ENSOANP00000009459 | ENSOANP00000012412 | MDM2 proto-oncogene. | Nucleophosmin 1. | 0.763 |
MDM2 | RPL5 | ENSOANP00000009459 | ENSOANP00000007399 | MDM2 proto-oncogene. | Ribosomal_L18_c domain-containing protein. | 0.865 |
MDM2 | TP53 | ENSOANP00000009459 | ENSOANP00000018980 | MDM2 proto-oncogene. | P53 domain-containing protein. | 0.999 |
NCL | K7EDB6_ORNAN | ENSOANP00000013915 | ENSOANP00000031523 | Uncharacterized protein. | Uncharacterized protein. | 0.484 |
page 1 of 3